ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Hammer Says President’s Science Advisory to Ask For FY 1985 Supplemental Appropriations for NCI

March 1, 1985

NCI-Approved Clinical Trials

August 25, 2006

NCI renews Roswell Park’s core grant for five years.

September 26, 2003

NCI’s SBIR Paylines Nears Regular Grants

September 20, 1985

Eye Institute Director Kupfer Steps Down; UICC Begins Web-Based Surgical Pathology.

July 7, 2000

New Design For NCI’s CancerNet Wins Prestigious Web Site Design Awards.

November 17, 2000